Toronto, Canada, June 21, 2019 – Namaste Technologies Inc. (“Namaste” or “the Company“) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) has determined that an email list of users registered with Namaste MD was uploaded by an employee to a third-party email solicitation provider for the purposes of soliciting unauthorized cannabis sales. It is believed that the emails were first uploaded to the third-party solicitation provider on May 4, 2019 following which affected Namaste MD users were sent emails over a period of 5 days and the situation was contained following Namaste’s detection and handling of the incident. Namaste has now completed its investigation of the facts and circumstances leading up to the incident and has taken appropriate action.
The Company determined that the source of the information was an employee of the Company affiliated with this website operator with whom the Company has no affiliation or relationship. The Company believes that other than a name and email address, no other personally identifiable information was used or accessed.
User privacy as well as data and information security are of the upmost importance to Namaste; therefore immediate action was taken by the third party email services provider to delete the affected name and email information from their database upon Namaste’s request.
The Company is taking steps to help protect registered users. The Company is in the process of hiring a security expert to assist in a review and revision of its internal data control and security policies, to better prevent incidents of this sort in the future. Namaste has contacted the impacted users to explain the nature and scope of the incident.
About Namaste Technologies Inc.
Namaste Technologies powers the ultimate online customer experience for medicinal cannabis and related products. Beginning with NamasteMD.com, the Company’s integrated telemedicine application, Namaste connects medical clients with health care practitioners to more readily issue and renew cannabis prescriptions online. Featuring the first Canadian Medical Sales-Only Licence, the Company’s Cannmart.com is your ‘everything cannabis store’ offering clients a large variety of strains to fill their prescription needs. Namaste’s unique artificial intelligence (AI) engine incorporated in its platforms and related Uppy App, completes our ecosystem by identifying the right product and pairing to address specific medical cannabis requirements. Namaste also provides vaporizers and accessories across several platforms. The Company’s global technology addresses local needs in a burgeoning cannabis industry requiring smart solutions. For more information about Namaste, please visit www.Namastetechnologies.com
For more information please contact:
Incite Capital Markets
Eric Negraeff / Darren Seed
For Meni Morim, CEO of Namaste
Email: [email protected]
Registered account users of Namaste MD can contact our customer service at [email protected] for customer related questions.
Further information on the Company and its products can be accessed through the links below:
FORWARD-LOOKING INFORMATION – This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as “may”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen. The forward-looking information contained herein is made as of the date of this press release and is based on assumptions management believed to be reasonable at the time such statements were made, including management’s perceptions of future growth, results of operations, operational matters, historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation: risks relating to the Company’s ability to execute its business strategy and the benefits realizable therefrom, risks specifically related to the Company’s international operations, and risks relating to the market price of the Common Shares, risks related to information and data privacy. Additional risk factors can also be found in the Company’s current MD&A and annual information form, both of which have been filed under the Company’s SEDAR profile at www.sedar.com. Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.